Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Little Green Pharma Ltd. ( (AU:LGP) ).
Little Green Pharma Ltd reported a significant revenue increase of 75% to $9.5 million for the December 2024 quarter, with cash receipts climbing 90% to $10.0 million. The company is experiencing strong growth in the German and UK markets, with $6.0 million in upcoming purchase orders, and has expanded its production facilities in Denmark to meet rising demand. The company also completed the acquisition of Health House and launched new products, enhancing its market position.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is a company in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is expanding its market reach in Europe, particularly in Germany and the UK, and has recently launched new products, including a craft flower brand, oil products, and a vaporiser.
YTD Price Performance: 0.0%
Average Trading Volume: 158,573
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$37.86M
See more insights into LGP stock on TipRanks’ Stock Analysis page.
